NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/20/2020
Back to search
Official data from USPTO
THE WORLD'S PUREST QUERCETIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
THE WORLD'S PUREST QUERCETIN
ST13
US500000077380737Class
5
Filing
77380737
Registration
3662137
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
03/20/2020
Trademark type
Word
Nice classes
5
Filing date
01/25/2008
Registration date
07/28/2009
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/20/2020
Last transaction
03/20/2020
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
06/11/2009
First use in commerce
06/11/2009
Drawing code
4
Owner type
16
Owner location
Boston, MA
Examiner
AQUILA, STEPHEN DAVID
Law office
M40
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
QUERCEGEN TECHNOLOGIES HOLDINGS LLC
Quercegen Pharma LLC
Quercegen Pharma LLC
Representatives
MICHAEL J. MACDERMOTT Lewis Roca Rothgerber Christie LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
NUTRITIONAL ADDITIVES FOR NUTRITIONAL USE IN FOODSBEVERAGES AND DIETARY SUPPLEMENTS FOR HUMAN CONSUMPTION; ALL OF THE FOREGOING CONTAINING QUERCETIN
Publications
History of USPTO decisions and trademark events.
40 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/20/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/20/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/20/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
01/23/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/28/2018
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
02/20/2016
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
02/20/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/20/2016
ES8R
TEAS SECTION 8 RECEIVED
01/28/2016
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/04/2013
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/04/2013
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/10/2011
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/16/2010
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/16/2010
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
07/28/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/20/2009
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
06/19/2009
IUAA
USE AMENDMENT ACCEPTED
06/19/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/15/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/15/2009
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
06/12/2009
IUAF
USE AMENDMENT FILED
06/12/2009
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/11/2009
EAAU
TEAS AMENDMENT OF USE RECEIVED
06/11/2009
EXPI
EX PARTE APPEAL-INSTITUTED
06/11/2009
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
06/11/2009
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
06/11/2009
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/11/2008
GNFR
FINAL REFUSAL E-MAILED
12/11/2008
CNFR
FINAL REFUSAL WRITTEN
12/11/2008
ACEC
AMENDMENT FROM APPLICANT ENTERED
11/26/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/26/2008
ALIE
ASSIGNED TO LIE
11/24/2008
PAPER RECEIVED
11/13/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/07/2008
GNRT
NON-FINAL ACTION E-MAILED
05/07/2008
CNRT
NON-FINAL ACTION WRITTEN
05/07/2008
DOCK
ASSIGNED TO EXAMINER
04/24/2008
NWAP
NEW APPLICATION ENTERED
01/29/2008
Continuous trademark protection
Get notified about every new filing that threatens THE WORLD'S PUREST QUERCETIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.